221 related articles for article (PubMed ID: 8632987)
1. Prevention of cardiovascular and renal pathology of aging by the advanced glycation inhibitor aminoguanidine.
Li YM; Steffes M; Donnelly T; Liu C; Fuh H; Basgen J; Bucala R; Vlassara H
Proc Natl Acad Sci U S A; 1996 Apr; 93(9):3902-7. PubMed ID: 8632987
[TBL] [Abstract][Full Text] [Related]
2. Aminoguanidine prevents age-related arterial stiffening and cardiac hypertrophy.
Corman B; Duriez M; Poitevin P; Heudes D; Bruneval P; Tedgui A; Levy BI
Proc Natl Acad Sci U S A; 1998 Feb; 95(3):1301-6. PubMed ID: 9448326
[TBL] [Abstract][Full Text] [Related]
3. Exogenous advanced glycosylation end products induce complex vascular dysfunction in normal animals: a model for diabetic and aging complications.
Vlassara H; Fuh H; Makita Z; Krungkrai S; Cerami A; Bucala R
Proc Natl Acad Sci U S A; 1992 Dec; 89(24):12043-7. PubMed ID: 1465438
[TBL] [Abstract][Full Text] [Related]
4. Aminoguanidine prevents age-related aortic stiffening in Fisher 344 rats: aortic impedance analysis.
Chang KC; Hsu KL; Peng YI; Lee FC; Tseng YZ
Br J Pharmacol; 2003 Sep; 140(1):107-14. PubMed ID: 12967940
[TBL] [Abstract][Full Text] [Related]
5. Aminoguanidine prevents arterial stiffening and cardiac hypertrophy in streptozotocin-induced diabetes in rats.
Chang KC; Hsu KL; Tseng CD; Lin YD; Cho YL; Tseng YZ
Br J Pharmacol; 2006 Apr; 147(8):944-50. PubMed ID: 16491102
[TBL] [Abstract][Full Text] [Related]
6. Aminoguanidine prevents age-related deterioration in left ventricular-arterial coupling in Fisher 344 rats.
Chang KC; Hsu KL; Chou TF; Lo HM; Tseng YZ
Br J Pharmacol; 2004 Aug; 142(7):1099-104. PubMed ID: 15249427
[TBL] [Abstract][Full Text] [Related]
7. Aminoguanidine prevents fructose-induced arterial stiffening in Wistar rats: aortic impedance analysis.
Lin YT; Tseng YZ; Chang KC
Exp Biol Med (Maywood); 2004 Nov; 229(10):1038-45. PubMed ID: 15522840
[TBL] [Abstract][Full Text] [Related]
8. Beneficial effect of Corni Fructus, a constituent of Hachimi-jio-gan, on advanced glycation end-product-mediated renal injury in Streptozotocin-treated diabetic rats.
Yamabe N; Kang KS; Goto E; Tanaka T; Yokozawa T
Biol Pharm Bull; 2007 Mar; 30(3):520-6. PubMed ID: 17329849
[TBL] [Abstract][Full Text] [Related]
9. Dietary glycotoxins: inhibition of reactive products by aminoguanidine facilitates renal clearance and reduces tissue sequestration.
He C; Sabol J; Mitsuhashi T; Vlassara H
Diabetes; 1999 Jun; 48(6):1308-15. PubMed ID: 10342821
[TBL] [Abstract][Full Text] [Related]
10. Effects of aminoguanidine on serum advanced glycation endproducts, urinary albilmin excretion, mesangial expansion, and glomerular basement membrane thickening in Otsuka Long-Evans Tokushima fatty rats.
Yamauchi A; Takei I; Makita Z; Nakamoto S; Ohashi N; Kiguchi H; Ishii T; Koike T; Saruta T
Diabetes Res Clin Pract; 1997 Jan; 34(3):127-33. PubMed ID: 9069563
[TBL] [Abstract][Full Text] [Related]
11. AGE formation blockade with aminoguanidine does not ameliorate chronic allograft nephropathy.
Schmaderer C; Xing CJ; Anderson G; Hermans R; Lutz J; Heemann U; Baumann M
Life Sci; 2011 Sep; 89(11-12):349-54. PubMed ID: 21763321
[TBL] [Abstract][Full Text] [Related]
12. ALT-946 and aminoguanidine, inhibitors of advanced glycation, improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.
Wilkinson-Berka JL; Kelly DJ; Koerner SM; Jaworski K; Davis B; Thallas V; Cooper ME
Diabetes; 2002 Nov; 51(11):3283-9. PubMed ID: 12401720
[TBL] [Abstract][Full Text] [Related]
13. Chronic aminoguanidine attenuates renal dysfunction and injury in aging rats.
Reckelhoff JF; Hennington BS; Kanji V; Racusen LC; Schmidt AM; Yan SD; Morrow J; Roberts LJ; Salahudeen AK
Am J Hypertens; 1999 May; 12(5):492-8. PubMed ID: 10342787
[TBL] [Abstract][Full Text] [Related]
14. Aminoguanidine and aortic wall mechanics, structure, and composition in aged rats.
Cantini C; Kieffer P; Corman B; Limiñana P; Atkinson J; Lartaud-Idjouadiene I
Hypertension; 2001 Oct; 38(4):943-8. PubMed ID: 11641314
[TBL] [Abstract][Full Text] [Related]
15. Aminoguanidine prevents arterial stiffening in a new rat model of type 2 diabetes.
Chang KC; Tseng CD; Wu MS; Liang JT; Tsai MS; Cho YL; Tseng YZ
Eur J Clin Invest; 2006 Aug; 36(8):528-35. PubMed ID: 16893374
[TBL] [Abstract][Full Text] [Related]
16. Effects of a new advanced glycation inhibitor, LR-90, on mitigating arterial stiffening and improving arterial elasticity and compliance in a diabetic rat model: aortic impedance analysis.
Satheesan S; Figarola JL; Dabbs T; Rahbar S; Ermel R
Br J Pharmacol; 2014 Jun; 171(12):3103-14. PubMed ID: 24611770
[TBL] [Abstract][Full Text] [Related]
17. Advanced glycation end products induce glomerular sclerosis and albuminuria in normal rats.
Vlassara H; Striker LJ; Teichberg S; Fuh H; Li YM; Steffes M
Proc Natl Acad Sci U S A; 1994 Nov; 91(24):11704-8. PubMed ID: 7972128
[TBL] [Abstract][Full Text] [Related]
18. Discordant effects of guanidines on renal structure and function and on regional vascular dysfunction and collagen changes in diabetic rats.
Nyengaard JR; Chang K; Berhorst S; Reiser KM; Williamson JR; Tilton RG
Diabetes; 1997 Jan; 46(1):94-106. PubMed ID: 8971088
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of Advanced Glycation End Products Formation Attenuates Cardiac Electrical and Mechanical Remodeling and Vulnerability to Tachyarrhythmias in Diabetic Rats.
Chang GJ; Yeh YH; Chen WJ; Ko YS; Pang JS; Lee HY
J Pharmacol Exp Ther; 2019 Jan; 368(1):66-78. PubMed ID: 30381326
[TBL] [Abstract][Full Text] [Related]
20. Aminoguanidine prevents the impairment of cardiac pumping mechanics in rats with streptozotocin and nicotinamide-induced type 2 diabetes.
Wu MS; Liang JT; Lin YD; Wu ET; Tseng YZ; Chang KC
Br J Pharmacol; 2008 Jun; 154(4):758-64. PubMed ID: 18376420
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
